Drug Recall & Adverse Event Reporting

OTC Drug Recall Management & Adverse Event Reporting System (AERS) Guidelines

Updated: Jun 2025QTC Global Compliance TeamRegulatory reference content

Mapping FDA FAERS reporting deadlines (15-day alert reports), PADER files, and mock recall testing procedures for OTC brand owners.

Key answer

Upon marketing, the responsible distributor/brand owner must establish a post-market safety reporting system. Serious and unexpected adverse events must be submitted to the FDA FAERS within 15 business days (15-Day Alert Report). Furthermore, companies must run periodic Mock Recalls to prove they can trace and contact all wholesalers and retailers within 24-48 hours during a recall.

Identifying & Reporting Serious Adverse Events

When brands receive negative product reviews, they must filter them to verify if they meet reporting criteria. Serious adverse events must be submitted by safety officers via the FDA Safety Reporting Portal (SRP) using Form 3500A.

  • Serious criteria: event causing death, life-threatening injury, hospitalization, disability, or congenital anomaly
  • 15-Day Alert limit: submission must occur within 15 business days from initial awareness (including verbal/web flags)
  • PADER files: Periodic Adverse Drug Experience Reports must be submitted quarterly for the first 3 years and annually thereafter

FAQ

What is the frequency and passing target for a Mock Recall?+

We recommend conducting a mock recall at least annually. The passing target is: within a defined window (usually 24 hours), tracing 100% of the target lot distributed to downstream channels, verifying shipped quantities, returns, and inventory with zero error.

Next steps

If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.